Mirtazapine Coupons & Discount Card - Compare Prices Near You

Antidepressant medications, such as mirtazapine (Remeron), are prescribed to treat depression and other mood disorders. While they offer significant benefits, there are important safety considerations to be aware of:

• Worsening Depression and Suicidal Thoughts: Antidepressants may increase the risk of suicidal thoughts, particularly in individuals under 25 years old or those with a history of mental health conditions. Immediate medical attention is crucial if suicidal thoughts or unusual behavioral changes occur. This is especially important when starting the medication or adjusting the dose.

• Infection Risk: Some individuals may experience a drop in white blood cell counts, leading to higher infection risk. Symptoms such as fever, fatigue, chills, cough, or breathing difficulties should be promptly reported to a healthcare provider.

• Serotonin Syndrome: There is a risk of developing serotonin syndrome, a potentially life-threatening condition caused by excessive serotonin levels. This risk increases if mirtazapine is taken with other serotonin-enhancing drugs. Symptoms include rapid heart rate, sweating, muscle stiffness, fever, and confusion. Medical attention is necessary if these symptoms arise.

• Withdrawal Symptoms: Abrupt discontinuation of mirtazapine can lead to withdrawal symptoms like nausea, anxiety, and dizziness. It's important to consult a healthcare provider for a safe discontinuation plan.

• Bipolar Disorder Caution: Antidepressants can trigger mania in individuals at risk of bipolar disorder. Monitoring for behavioral changes is essential.

• Glaucoma Concerns: Mirtazapine may exacerbate angle-closure glaucoma. Regular eye exams are recommended, and any vision changes should be reported.

• Heart Rhythm Issues (QT Prolongation): This medication can affect heart rhythm, particularly in individuals with electrolyte imbalances or pre-existing heart conditions. Monitoring via electrocardiograms (EKGs) may be necessary.

• Severe Allergic Reactions: Severe allergic reactions, including anaphylaxis and serious skin conditions, can occur. Immediate medical attention is required if symptoms like swelling or skin changes appear.

• Cognitive and Sedation Effects: Mirtazapine may cause drowsiness and impair concentration. Caution is advised when driving or operating machinery, especially if combined with other sedative drugs.

• Seizure Risk: Individuals with a history of seizures should discuss this with their healthcare provider before starting mirtazapine.

• Low Sodium Levels: Older adults or those on diuretics may experience low blood sodium levels. Symptoms like confusion and weakness require urgent medical evaluation.

• Phenylketonuria (PKU) Warning: The orally disintegrating tablets contain phenylalanine; individuals with PKU should consider alternative formulations.

Contraindications: Mirtazapine should not be used in combination with MAO inhibitors, linezolid, or methylene blue within the last 14 days due to serious health risks. Always consult a healthcare provider if these conditions apply.

Common side effects:

• Dizziness
• Drowsiness
• Lightheadedness
• Increased appetite
• Weight gain
• Dry mouth
• Constipation

Less common but important to monitor:

• Strange dreams
• Flu-like symptoms
• Muscle pain
• Increased urination
• Swelling in hands or feet
• Tremors
• Confusion

Serious side effects:

• Serotonin syndrome (rapid heartbeat, severe dizziness, hallucinations, unexplained agitation)
• Abnormal heart rhythms
• Seizures
• Severe allergic reactions (swelling of face, lips, or tongue, difficulty breathing)
• Serious skin reactions (hives, rashes, blisters)
• Low blood sodium levels (nausea, fatigue, headache, seizures, unconsciousness)

Interactions with high risk of serious adverse effects and should be avoided:

• MAO inhibitors (isocarboxazid, Linezolid, methylene blue, moclobemide, phenelzine, procarbazine, Rasagiline, safinamide, Selegiline, Tranylcypromine)

Interactions with moderate risk that may require dose adjustment, closer monitoring, or timing changes:

• Drugs that increase serotonin (SSRIs such as Fluoxetine/paroxetine, SNRIs such as Duloxetine/Venlafaxine, Tryptophan, MDMA)

Interactions with low risk that usually do not require a change in therapy:

• Products that cause drowsiness (alcohol, marijuana, antihistamines such as Cetirizine/diphenhydramine, sleep or anxiety medications such as Alprazolam/Diazepam/Zolpidem, muscle relaxants such as Carisoprodol/Cyclobenzaprine, opioid pain relievers such as codeine/hydrocodone)